LTR Pharma (ASX:LTP) FCF Margin %: -6,643.24% (As of Dec. 2025)


ASX:LTP LTR Pharma Ltd ASX:LTP
15 GF Score
Price A$0.56
! 1 Warning Sign
View Full Analysis

What is LTR Pharma FCF Margin %?

LTR Pharma ASX:LTP -4.27% 15 FCF Margin % is -6,643.24% as of Dec. 2025. GuruFocus rates ASX:LTP with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, LTR Pharma ranks worse than 89.16% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. LTR Pharma's Free Cash Flow for the six months ended in Dec. 2025 was A$-4.92 Mil. LTR Pharma's Revenue for the six months ended in Dec. 2025 was A$0.07 Mil. Therefore, LTR Pharma's FCF Margin % for the quarter that ended in Dec. 2025 was -6,643.24%.

As of today, LTR Pharma's current FCF Yield % is -6.83%.

The historical rank and industry rank for LTR Pharma's FCF Margin % or its related term are showing as below:

ASX:LTP' s FCF Margin % Range Over the Past 10 Years
Min: -4435.67   Med: -3047.26   Max: -3047.26
Current: -4435.67

During the past 5 years, the highest FCF Margin % of LTR Pharma was -3047.26%. The lowest was -4435.67%. And the median was -3047.26%.

ASX:LTP's FCF Margin % is ranked worse than
89.16% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs ASX:LTP: -4435.67

LTR Pharma FCF Margin % Related Terms

LTR Pharma FCF Margin % Historical Data

* Premium members only.

The historical data trend for LTR Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma FCF Margin % Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
FCF Margin %
0.00 0.00 0.00 0.00 -3,047.26

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial 0.00 0.00 -3,812.70 -2,467.47 -6,643.24

ASX:LTP vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, LTR Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LTR Pharma FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LTR Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where LTR Pharma's FCF Margin % falls into.


ASX:LTP
15GF Score
LTR Pharma Ltd ASX:LTP
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

LTR Pharma's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-4.449/0.146
=-3,047.26 %

LTR Pharma's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-4.916/0.074
=-6,643.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -6,643.24% mean?
LTR Pharma (ASX:LTP) has a FCF Margin % of -6,643.24% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on LTR Pharma and its competitors. According to the industry distribution chart, LTR Pharma ranks #855 out of 959 companies in the Biotechnology industry, placing it in the top 89.2%.
Is LTR Pharma's FCF Margin % too high?
LTR Pharma's current FCF Margin % is -6,643.24%. Based on the distribution chart, LTR Pharma ranks #855 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, LTR Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, LTR Pharma ranks #855 out of 959 companies for FCF Margin %. This places LTR Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on LTR Pharma and its competitors. LTR Pharma's current FCF Margin % is -6,643.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current FCF Margin % of -6,643.24%. The current FCF Margin % is -6,643.24%. LTR Pharma's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current FCF Margin % is -6,643.24% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
15GF Score

Get the complete analysis for ASX:LTP

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.56
Price